Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
Isabelle Mahé, Head of Internal Medicine, Louis Mourier Hospital, APHP, Paris Cité University, shared on LinkedIn:
”The Proposals from the French multidisciplinary INNOVTE CAT Working Group for the management of cancer-associated thromboembolism have been published in ACVD.
Executive summary.”
Venous thromboembolism (VTE) is a frequent and serious complication in cancer patients, with rising incidence but declining mortality, leading to a growing population requiring long-term management of cancer-associated thrombosis (CAT).
Because CAT care is increasingly complex, a multidisciplinary French working group reviewed challenges in real-world practice—including care pathways, home management, treatment decisions, and management of special populations such as the elderly, patients with renal impairment, brain tumors, thrombocytopenia, or central venous catheters.
The group highlights significant gaps in evidence, particularly for high-risk subgroups and recurrent VTE, and proposes practical guidance to improve coordination and clinical decision-making across specialties.
Read the full article here.
Article: The management of cancer-associated thromboembolism: Proposals from the French multidisciplinary INNOVTE CAT Working Group
Authors: Isabelle Mahé, Ygal Benhamou, Asmahane Benmaziane, Laurent Bertoletti, Virginie Bichon, Coralie Bozec, Ariel Cohen, Francis Couturaud, Philippe Debourdeau, Pascale Dielenseger, Éric Douriez, Antoine Elias, Olivier Espitia, Corinne Frère, Yoann Gaboreau, Pascale Gendron, Philippe Girard, Olivier Hanon, Ahmed Idbaih, Silvy Laporte, Didier Mayeur, Farès Moustafa, Gilles Pernod, Pierre-Marie Roy, Marie-Eve Rouge Bugat, Jeannot Schmidt, Florian Scotte, Marie-Antoinette Sevestre, Patrick Mismetti, Olivier Sanchez
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 23, 2026, 20:46Grace Choung: A Novel CFHR5 Copy Number Variant in Postpartum Atypical HUS
-
Jul 23, 2026, 20:10Mohammad Alzoubi: One Month of Dual Antithrombotic Therapy After PCI Was Non-Inferior to 12 Months
-
Jul 23, 2026, 20:08Ahmed Bennis: Calcitriol Replenishment May Mitigate Ischemic Risk in MASLD
-
Jul 23, 2026, 20:06Mitsuaki Sawano: Can Cardiovascular Risk Prediction Models Developed in One Population be Reliably Applied to Another?
-
Jul 23, 2026, 20:05Abdul Muqtadir Abbasi: Hemostasis Isn’t About Memorizing Factor Numbers – It’s About Recognizing Patterns
-
Jul 23, 2026, 19:40Maureen Macharia: How Apixaban Transformed Modern Anticoagulation
-
Jul 23, 2026, 19:30Jordan Agay: Why We Need to Track the Neurological Costs of Anemia
-
Jul 23, 2026, 19:25William Archibald: Key Takeaways on VTE Cost-Effectiveness and Cancer Associated Thrombosis from ISTH 2026
-
Jul 23, 2026, 19:17Diego López Santos: Donation after Donation, I Just Reached 100